Valuation (69%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 8.97 | 37.14 |
PEG Ratio (TTM) | -0.72 | 3.43 |
P/S Ratio (TTM) | 1.11 | 3.39 |
P/B Ratio (TTM) | -4.74 | 6.58 |
P/FCF Ratio (TTM) | 12.86 | 43.57 |
Price to 5YR AVG Earnings Ratio | 13.64 | 80.86 |
Price to 5YR AVG FCF Ratio | 7.83 | 131.10 |
Profitability (60%) |
Company | Industry |
---|---|---|
ROA (TTM) | 18.54% | 6.59% |
ROE (TTM) | -54.58% | 11.65% |
Net Profit Margin (TTM) | 12.43% | 6.47% |
ROIC 5YR AVG | 38.57% | 15.81% |
Growth (72%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 88.96% | 78.22% | 43.39% |
Revenue | 12.43% | -5.88% | -4.69% |
Net Income | 86.51% | 77.24% | 40.29% |
Cash Flow | 405.57% | 9.30% | -2.41% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.09 | 1.27 |
Quick Ratio (TTM) | 0.34 | 0.90 |
D/E Ratio (TTM) | -3.06 | 1.58 |
Interest Coverage (TTM) | 3.98 | 16.76 |
Piotroski F-Score | 7 | 7 |
Altman Z-Score | 2.62 | 4.59 |
LTL to 5YR AVG FCF | 5.10 | 18.53 |
Shares Outstanding Growth 5YR AVG | -3.78% | 39.48% |